Title Delta (2308 TT) Buy, TP raised to NT$329
  Sercomm (5388 TT) Buy, TP of NT$95 (16x 2021F P/E)
  Universal Vision Biotechnology (3218 TT) U/G Buy, TP: NT$330
  Nanya Tech (2408 TT) Buy, TP raised to NT$116
  Largan (3008 TT) Neutral
  BenQ Materials (8215 TT) U/G Buy, TP: NT$33
  Kinsus (3189 TT) Buy, TP: NT$109
  Airtac International (1590 TT) Buy, TP: NT$1,080
  TaiDoc (4736 TT) Buy, TP: NT$222
  Sinbon (3023 TT) Buy, TP: NT$238
More Titles
Title:Sporton (6146 TT) Buy, TP: NT$316
Download File:6146 TT Sporton note 201222--sinopac.pdf 
Summary:Maintain Buy, TP of NT$316 (30x 2021F P/E): 1) Sporton¡¯s 5G handset testing projects have grown from 12-13 projects in 2019 to 80 projects as of SEP in 2020. We estimate Sporton will test 100 5G handset models this year, surpassing the company¡¯s guidance of 80 models. 2) We raise our 4Q20 GM estimate from 45% to 46.1% and raise our 2021 GM estimate from 46.9% to 48.1%, and we raise our 2021 EPS estimate to NT$10.96 from NT$10.54. 3) Valuation: The stock is trading at 23x 201F P/E, vs. historical range of 15-30x. We set our TP at 30x because a) we anticipate an EPS leap forward in the 5G era (from NT$7.27 in 2019 to NT$8.28/NT$10.96 in 2020F/2021F) like we saw with the transition from 3G to 4G (EPS ramped from NT$5 to NT$7-8 level, b) we assume Sporton can achieve ROE of 30% in 2021F, and c) Sporton maintains a stable dividend payout of 80%.
Register online at Become Member to receive Taiwan research services. For more information, contact TaiwanResearch.com. Tel (8862) 2316-5181
©2001, 2000, 1999 SinoPac All rights reserved. Additional copyright information applies.